Glutathione S-transferase and MRP1 form an integrated system involved in the storage and transport of dinitrosyl-dithiolato iron complexes in cells

Free Radical Biology and Medicine

Volumn 75, Issue , 2014, Pages 14-29

  Lok, H C ^a   Sahni, S ^a   Richardson, V ^a   Kalinowski, D S ^a   Kovacevic, Z ^a   Lane, D J R ^a   Richardson, D R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dinitrosyl dithiolato iron complexes; Free radicals; Nitrogen monoxide; Protein metal ion interactions

Indexed keywords

DINITROSYL DITHIOLATO IRON COMPLEX; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IRON COMPLEX; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; NITRIC OXIDE; NITRITE; UNCLASSIFIED DRUG; DINITROSYL IRON THIOSULFATE; IRON; IRON DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; NITROGEN OXIDE;

BIOLOGICAL FUNCTIONS; CANCER RESISTANCE; CYTOTOXICITY; DRUG RESISTANCE; ELECTRON SPIN RESONANCE; ENERGY METABOLISM; ENZYME ACTIVITY; HUMAN; IRON KINETICS; IRON STORAGE; IRON TRANSPORT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; ANIMAL; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE TRANSFERASE; HUMANS; IRON; IRON COMPOUNDS; MACROPHAGES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NITRIC OXIDE; NITROGEN OXIDES;

EID: 84905563078     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.07.002     Document Type: Review

References (224)

1. M.A. Marletta Nitric oxide synthase: aspects concerning structure and catalysis Cell 78 1994 927 930
2. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43 1991 109 142
3. J.B. Hibbs Jr., R.R. Taintor, and Z. Vavrin Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages Biochem. Biophys. Res. Commun. 123 1984 716 723
4. J.B. Hibbs Jr., R.R. Taintor, Z. Vavrin, and E.M. Rachlin Nitric oxide: a cytotoxic activated macrophage effector molecule Biochem. Biophys. Res. Commun. 157 1988 87 94
5. C. Nathan, and Q.W. Xie Regulation of biosynthesis of nitric oxide J. Biol. Chem. 269 1994 13725 13728
6. D.J. Stuehr, S.S. Gross, I. Sakuma, R. Levi, and C.F. Nathan Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide J. Exp. Med. 169 1989 1011 1020
7. M.A. Marletta Nitric oxide synthase structure and mechanism J. Biol. Chem. 268 1993 12231 12234
8. U. Forstermann, and W.C. Sessa Nitric oxide synthases: regulation and function Eur. Heart J. 33 829-837 2012 (837a-837d)
9. J.B. Hibbs Jr., C. Westenfelder, R. Taintor, Z. Vavrin, C. Kablitz, R.L. Baranowski, J.H. Ward, R.L. Menlove, M.P. McMurry, and J.P. Kushner et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy J. Clin. Invest. 89 1992 867 877
10. J.B. Hibbs Jr., R.R. Taintor, and Z. Vavrin Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite Science 235 1987 473 476
11. J.S. Stamler, D.J. Singel, and J. Loscalzo Biochemistry of nitric oxide and its redox-activated forms Science 258 1992 1898 1902
12. A.F. Vanin, L.A. Bliumenfel'd, and A.G. Chetverikov [EPR study of non-heme iron complexes in cells and tissues] Biofizika 12 1967 829 838
13. A.F. Vanin Endothelium-derived relaxing factor is a nitrosyl iron complex with thiol ligands FEBS Lett. 289 1991 1 3
14. A.F. Vanin Dinitrosyl iron complexes and S-nitrosothiols are two possible forms for stabilization and transport of nitric oxide in biological systems Biochemistry (Moscow) 63 1998 782 793
15. A.F. Vanin, V.A. Serezhenkov, V.D. Mikoyan, and M.V. Genkin The 2.03 signal as an indicator of dinitrosyl-iron complexes with thiol-containing ligands Nitric Oxide 2 1998 224 234
16. D.R. Richardson, and P. Ponka The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells Biochim. Biophys. Acta 1331 1997 1 40
17. R.N. Watts, P. Ponka, and D.R. Richardson Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: mirror-image effector molecules that target iron Biochem. J. 369 2003 429 440
18. C.A. Bosworth, J.C. Toledo Jr., J.W. Zmijewski, Q. Li, and J.R. Lancaster Jr. Dinitrosyliron complexes and the mechanism(s) of cellular protein nitrosothiol formation from nitric oxide Proc. Natl. Acad. Sci. USA 106 2009 4671 4676
19. J.C. Drapier, and J.B. Hibbs Jr. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells: inhibition involves the iron-sulfur prosthetic group and is reversible J. Clin. Invest. 78 1986 790 797
20. M. Lepoivre, F. Fieschi, J. Coves, L. Thelander, and M. Fontecave Inactivation of ribonucleotide reductase by nitric oxide Biochem. Biophys. Res. Commun. 179 1991 442 448
21. Y.M. Kim, H.A. Bergonia, C. Muller, B.R. Pitt, W.D. Watkins, and J.R. Lancaster Jr. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis J. Biol. Chem. 270 1995 5710 5713
22. M.W. Cleeter, J.M. Cooper, V.M. Darley-Usmar, S. Moncada, and A.H. Schapira Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide: implications for neurodegenerative diseases FEBS Lett. 345 1994 50 54
23. L.J. Ignarro Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism Blood Vessels 28 1991 67 73
24. O.G. Khatsenko, S.S. Gross, A.B. Rifkind, and J.R. Vane Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants Proc. Natl. Acad. Sci. USA 90 1993 11147 11151
25. P. Sarti, A. Giuffre, M.C. Barone, E. Forte, D. Mastronicola, and M. Brunori Nitric oxide and cytochrome oxidase: reaction mechanisms from the enzyme to the cell Free Radic. Biol. Med. 34 2003 509 520
26. R. Chowdhury, E. Flashman, J. Mecinovic, H.B. Kramer, B.M. Kessler, Y.M. Frapart, J.L. Boucher, I.J. Clifton, M.A. McDonough, and C.J. Schofield Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1) J. Mol. Biol. 410 2011 268 279
27. J.R. Hickok, D. Vasudevan, W.E. Antholine, and D.D. Thomas Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases J. Biol. Chem. 288 2013 16004 16015
28. M. Lee, P. Arosio, A. Cozzi, and N.D. Chasteen Identification of the EPR-active iron-nitrosyl complexes in mammalian ferritins Biochemistry 33 1994 3679 3687
29. J.C. Drapier, and J.B. Hibbs Jr. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells J. Immunol. 140 1988 2829 2838
30. J.P. Bolanos, S. Peuchen, S.J. Heales, J.M. Land, and J.B. Clark Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes J. Neurochem. 63 1994 910 916
31. D.R. Richardson, V. Neumannova, E. Nagy, and P. Ponka The effect of redox-related species of nitrogen monoxide on transferrin and iron uptake and cellular proliferation of erythroleukemia (K562) cells Blood 86 1995 3211 3219
32. S.L. Wardrop, R.N. Watts, and D.R. Richardson Nitrogen monoxide activates iron regulatory protein 1 RNA-binding activity by two possible mechanisms: effect on the [4Fe-4S] cluster and iron mobilization from cells Biochemistry 39 2000 2748 2758
33. P. Ponka, C. Beaumont, and D.R. Richardson Function and regulation of transferrin and ferritin Semin. Hematol. 35 1998 35 54
34. M.W. Hentze, and L.C. Kuhn Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress Proc. Natl. Acad. Sci. USA 93 1996 8175 8182
35. E.G. Meyron-Holtz, M.C. Ghosh, K. Iwai, T. LaVaute, X. Brazzolotto, U.V. Berger, W. Land, H. Ollivierre-Wilson, A. Grinberg, P. Love, and T.A. Rouault Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis EMBO J. 23 2004 386 395
36. A. Stys, B. Galy, R.R. Starzynski, E. Smuda, J.C. Drapier, P. Lipinski, and C. Bouton Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide J. Biol. Chem. 286 2011 22846 22854
37. J.C. Drapier, H. Hirling, J. Wietzerbin, P. Kaldy, and L.C. Kuhn Biosynthesis of nitric oxide activates iron regulatory factor in macrophages EMBO J. 12 1993 3643 3649
38. G. Weiss, B. Goossen, W. Doppler, D. Fuchs, K. Pantopoulos, G. Werner-Felmayer, H. Wachter, and M.W. Hentze Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway EMBO J. 12 1993 3651 3657
39. R.N. Watts, and D.R. Richardson Examination of the mechanism of action of nitrogen monoxide on iron uptake from transferrin J. Lab. Clin. Med. 136 2000 149 156
40. R.N. Watts, and D.R. Richardson Differential effects on cellular iron metabolism of the physiologically relevant diatomic effector molecules, NO and CO, that bind iron Biochim. Biophys. Acta 1692 2004 1 15
41. D.R. Richardson, V. Neumannova, and P. Ponka Nitrogen monoxide decreases iron uptake from transferrin but does not mobilise iron from prelabelled neoplastic cells Biochim. Biophys. Acta 1266 1995 250 260
42. F. Feger, H. Ferry-Dumazet, M. Mamani Matsuda, J. Bordenave, M. Dupouy, A.K. Nussler, M. Arock, L. Devevey, J. Nafziger, J.J. Guillosson, J. Reiffers, and M.D. Mossalayi Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide Cancer Res. 61 2001 5289 5294
43. D.T. Hess, A. Matsumoto, S.O. Kim, H.E. Marshall, and J.S. Stamler Protein S-nitrosylation: purview and parameters Nat. Rev. Mol. Cell Biol. 6 2005 150 166
44. J.R. Hickok, D. Vasudevan, G.R. Thatcher, and D.D. Thomas Is S-nitrosocysteine a true surrogate for nitric oxide? Antioxid. Redox Signaling 17 2012 962 968
45. D. Fukumura, S. Kashiwagi, and R.K. Jain The role of nitric oxide in tumour progression Nat. Rev. Cancer 6 2006 521 534
46. L.J. Hofseth, S.P. Hussain, G.N. Wogan, and C.C. Harris Nitric oxide in cancer and chemoprevention Free Radic. Biol. Med. 34 2003 955 968
47. J.A. Crowell, V.E. Steele, C.C. Sigman, and J.R. Fay Is inducible nitric oxide synthase a target for chemoprevention? Mol. Cancer Ther. 2 2003 815 823
48. K. Forrester, S. Ambs, S.E. Lupold, R.B. Kapust, E.A. Spillare, W.C. Weinberg, E. Felley-Bosco, X.W. Wang, D.A. Geller, E. Tzeng, T.R. Billiar, and C.C. Harris Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53 Proc. Natl. Acad. Sci. USA 93 1996 2442 2447
49. X. Wang, A. Zalcenstein, and M. Oren Nitric oxide promotes p53 nuclear retention and sensitizes neuroblastoma cells to apoptosis by ionizing radiation Cell Death Differ. 10 2003 468 476
50. J.R. Hickok, S. Sahni, Y. Mikhed, M.G. Bonini, and D.D. Thomas Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron J. Biol. Chem. 286 2011 41413 41424
51. Z. Kovacevic, and D.R. Richardson The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer Carcinogenesis 27 2006 2355 2366
52. N.T. Le, and D.R. Richardson Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation Blood 104 2004 2967 2975
53. B.A. Fang, Z. Kovacevic, K.C. Park, D.S. Kalinowski, P.J. Jansson, D.J. Lane, S. Sahni, and D.R. Richardson Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy Biochim. Biophys. Acta 1845 2014 1 19
54. T.P. Ellen, Q. Ke, P. Zhang, and M. Costa NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states Carcinogenesis 29 2008 2 8
55. D.J. Lane, F. Saletta, Y. Suryo Rahmanto, Z. Kovacevic, and D.R. Richardson N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion PLoS One 8 2013 e57273
56. J. Sun, D. Zhang, D.H. Bae, S. Sahni, P. Jansson, Y. Zheng, Q. Zhao, F. Yue, M. Zheng, Z. Kovacevic, and D.R. Richardson Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors Carcinogenesis 34 2013 1943 1954
57. Z. Chen, D. Zhang, F. Yue, M. Zheng, Z. Kovacevic, and D.R. Richardson The iron chelators Dp44mT and DFO inhibit TGF-beta-induced epithelial- mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1) J. Biol. Chem. 287 2012 17016 17028
58. Z. Kovacevic, S. Chikhani, G.Y. Lui, S. Sivagurunathan, and D.R. Richardson The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways Antioxid. Redox Signaling 18 2013 874 887
59. R. Jin, W. Liu, S. Menezes, F. Yue, M. Zheng, Z. Kovacevic, and D.R. Richardson The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation β-catenin through mechanisms involving FRAT1 and PAK4 J. Cell Sci. 127 2014 3116 3130
60. K.M. Dixon, G.Y. Lui, Z. Kovacevic, D. Zhang, M. Yao, Z. Chen, Q. Dong, S.J. Assinder, and D.R. Richardson Dp44mT targets the AKT, TGF-beta and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells Br. J. Cancer 108 2013 409 419
61. J. Sun, D. Zhang, Y. Zheng, Q. Zhao, M. Zheng, Z. Kovacevic, and D.R. Richardson Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway Mol. Pharmacol. 83 2013 454 469
62. H.C. Lok, Y. Suryo Rahmanto, C.L. Hawkins, D.S. Kalinowski, C.S. Morrow, A.J. Townsend, P. Ponka, and D.R. Richardson Nitric oxide storage and transport in cells are mediated by glutathione S-transferase P1-1 and multidrug resistance protein 1 via dinitrosyl iron complexes J. Biol. Chem. 287 2012 607 618
63. R.N. Watts, C. Hawkins, P. Ponka, and D.R. Richardson Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multidrug resistance-associated protein 1 Proc. Natl. Acad. Sci. USA 103 2006 7670 7675
64. R.N. Watts, and D.R. Richardson Nitrogen monoxide (NO) and glucose: unexpected links between energy metabolism and NO-mediated iron mobilization from cells J. Biol. Chem. 276 2001 4724 4732
65. S.A. Lipton, Y.B. Choi, Z.H. Pan, S.Z. Lei, H.S. Chen, N.J. Sucher, J. Loscalzo, D.J. Singel, and J.S. Stamler A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds Nature 364 1993 626 632
66. J.B. Hibbs Jr. Activated macrophages as cytotoxic effector cells. II. Requirement for local persistence of inducing antigen Transplantation 19 1975 81 87
67. J.B. Hibbs Jr., L.H. Lambert Jr., and J.S. Remington Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance Nat. New Biol. 235 1972 48 50
68. J.E. Albina, and J.S. Reichner Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis Cancer Metastasis Rev. 17 1998 39 53
69. J.B. Hibbs Jr., L.H. Lambert Jr., and J.S. Remington Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni J. Infect. Dis. 124 1971 587 592
70. R. Keller Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages J. Exp. Med. 138 1973 625 644
71. Y. Henry, C. Ducrocq, J.C. Drapier, D. Servent, C. Pellat, and A. Guissani Nitric oxide, a biological effector: electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells Eur. Biophys. J. 20 1991 1 15
72. J.R. Lancaster Jr., and J.B. Hibbs Jr. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages Proc. Natl. Acad. Sci. USA 87 1990 1223 1227
73. C. Pellat, Y. Henry, and J.C. Drapier IFN-γ-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins Biochem. Biophys. Res. Commun. 166 1990 119 125
74. J.C. Woolum, E. Tiezzi, and B. Commoner Electron spin resonance of iron-nitric oxide complexes with amino acids, peptides and proteins Biochim. Biophys. Acta 160 1968 311 320
75. N.R. Bastian, C.Y. Yim, J.B. Hibbs Jr., and W.E. Samlowski Induction of iron-derived EPR signals in murine cancers by nitric oxide: evidence for multiple intracellular targets J. Biol. Chem. 269 1994 5127 5131
76. B. Commoner, J.C. Woolum, B.H. Senturia Jr., and J.L. Ternberg The effects of 2-acetylaminofluorene and nitrite on free radicals and carcinogenesis in rat liver Cancer Res. 30 1970 2091 2097
77. J.C. Drapier, C. Pellat, and Y. Henry Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages J. Biol. Chem. 266 1991 10162 10167
78. A.F. Vanin, G.B. Men'shikov, I.A. Moroz, P.I. Mordvintcev, V.A. Serezhenkov, and D. Burbaev The source of non-heme iron that binds nitric oxide in cultivated macrophages Biochim. Biophys. Acta 1135 1992 275 279
79. J.R. Hickok, S. Sahni, H. Shen, A. Arvind, C. Antoniou, L.W. Fung, and D.D. Thomas Dinitrosyliron complexes are the most abundant nitric oxide-derived cellular adduct: biological parameters of assembly and disappearance Free Radic. Biol. Med. 51 2011 1558 1566
80. Q. Li, C. Li, H.K. Mahtani, J. Du, A.R. Patel, and J.R. Lancaster Jr. Nitrosothiol formation and protection against Fenton chemistry by nitric oxide-induced dinitrosyliron complex formation from anoxia-initiated cellular chelatable iron increase J. Biol. Chem. 289 2014 19917 19927
81. F. De Maria, J.Z. Pedersen, A.M. Caccuri, G. Antonini, P. Turella, L. Stella, M. Lo Bello, G. Federici, and G. Ricci The specific interaction of dinitrosyl-diglutathionyl-iron complex, a natural NO carrier, with the glutathione transferase superfamily: suggestion for an evolutionary pressure in the direction of the storage of nitric oxide J. Biol. Chem. 278 2003 42283 42293
82. A. Mulsch, P. Mordvintcev, A.F. Vanin, and R. Busse The potent vasodilating and guanylyl cyclase activating dinitrosyl-iron(II) complex is stored in a protein-bound form in vascular tissue and is released by thiols FEBS Lett. 294 1991 252 256
83. P. Turella, J.Z. Pedersen, A.M. Caccuri, F. De Maria, P. Mastroberardino, M. Lo Bello, G. Federici, and G. Ricci Glutathione transferase superfamily behaves like storage proteins for dinitrosyl-diglutathionyl-iron complex in heterogeneous systems J. Biol. Chem. 278 2003 42294 42299
84. T. Ueno, Y. Suzuki, S. Fujii, A.F. Vanin, and T. Yoshimura In vivo distribution and behavior of paramagnetic dinitrosyl dithiolato iron complex in the abdomen of mouse Free Radic. Res. 31 1999 525 534
85. T. Ueno, Y. Suzuki, S. Fujii, A.F. Vanin, and T. Yoshimura In vivo nitric oxide transfer of a physiological NO carrier, dinitrosyl dithiolato iron complex, to target complex Biochem. Pharmacol. 63 2002 485 493
86. N. Ballatori, C.L. Hammond, J.B. Cunningham, S.M. Krance, and R. Marchan Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins Toxicol. Appl. Pharmacol. 204 2005 238 255
87. A. Bocedi, R. Fabrini, A. Farrotti, L. Stella, A.J. Ketterman, J.Z. Pedersen, N. Allocati, P.C. Lau, S. Grosse, L.D. Eltis, A. Ruzzini, T.E. Edwards, L. Morici, E. Del Grosso, L. Guidoni, D. Bovi, M. Lo Bello, G. Federici, M.W. Parker, P.G. Board, and G. Ricci The impact of nitric oxide toxicity on the evolution of the glutathione transferase superfamily: a proposal for an evolutionary driving force J. Biol. Chem. 288 2013 24936 24947
88. J.C. Toledo Jr., C.A. Bosworth, S.W. Hennon, H.A. Mahtani, H.A. Bergonia, and J.R. Lancaster Jr. Nitric oxide-induced conversion of cellular chelatable iron into macromolecule-bound paramagnetic dinitrosyliron complexes J. Biol. Chem. 283 2008 28926 28933
89. A.F. Vanin Dinitrosyl iron complexes with thiolate ligands: physico-chemistry, biochemistry and physiology Nitric Oxide 21 2009 1 13
90. M. Boese, M.A. Keese, K. Becker, R. Busse, and A. Mulsch Inhibition of glutathione reductase by dinitrosyl-iron-dithiolate complex J. Biol. Chem. 272 1997 21767 21773
91. K. Becker, S.N. Savvides, M. Keese, R.H. Schirmer, and P.A. Karplus Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers Nat. Struct. Biol. 5 1998 267 271
92. N.Y. Giliano, L.V. Konevega, L.A. Noskin, V.A. Serezhenkov, A.P. Poltorakov, and A.F. Vanin Dinitrosyl iron complexes with thiol-containing ligands and apoptosis: studies with HeLa cell cultures Nitric Oxide 24 2011 151 159
93. K.B. Shumaev, A.A. Gubkin, V.A. Serezhenkov, I.I. Lobysheva, O.V. Kosmachevskaya, E.K. Ruuge, V.Z. Lankin, A.F. Topunov, and A.F. Vanin Interaction of reactive oxygen and nitrogen species with albumin- and methemoglobin-bound dinitrosyl-iron complexes Nitric Oxide 18 2008 37 46
94. Y.M. Kim, H.T. Chung, R.L. Simmons, and T.R. Billiar Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition J. Biol. Chem. 275 2000 10954 10961
95. A.L. Kleschyov, S. Strand, S. Schmitt, D. Gottfried, M. Skatchkov, N. Sjakste, A. Daiber, V. Umansky, and T. Munzel Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2 Free Radic. Biol. Med. 40 2006 1340 1348
96. C.C. Philpott Coming into view: eukaryotic iron chaperones and intracellular iron delivery J. Biol. Chem. 287 2012 13518 13523
97. S. Leidgens, K.Z. Bullough, H. Shi, F. Li, M. Shakoury-Elizeh, T. Yabe, P. Subramanian, E. Hsu, N. Natarajan, A. Nandal, T.L. Stemmler, and C.C. Philpott Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin J. Biol. Chem. 288 2013 17791 17802
98. Y. Suryo Rahmanto, D.S. Kalinowski, D.J. Lane, H.C. Lok, V. Richardson, and D.R. Richardson Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteins J. Biol. Chem. 287 2012 6960 6968
99. A. Anzovino, D.J. Lane, M.L. Huang, and D.R. Richardson Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia Br. J. Pharmacol. 171 2014 2174 2190
100. K.B. Shumaev, N.E. Petrova, I.V. Zabbarova, A.F. Vanin, A.F. Topunov, V.Z. Lankin, and E.K. Ruuge Interaction of oxoferrylmyoglobin and dinitrosyl-iron complexes Biochemistry (Moscow) 69 2004 569 574
101. K.B. Shumaev, O.V. Kosmachevskaya, A.A. Timoshin, A.F. Vanin, and A.F. Topunov Dinitrosyl iron complexes bind with hemoglobin as markers of oxidative stress Methods Enzymol. 436 2008 445 461
102. E.I. Chazov, O.V. Rodnenkov, A.V. Zorin, V.L. Lakomkin, V.V. Gramovich, O.N. Vyborov, A.G. Dragnev, C.A. Timoshin, L.I. Buryachkovskaya, A.A. Abramov, V.P. Massenko, E.V. Arzamastsev, V.I. Kapelko, and A.F. Vanin Hypotensive effect of Oxacom(R) containing a dinitrosyl iron complex with glutathione: animal studies and clinical trials on healthy volunteers Nitric Oxide 26 2012 148 156
103. V.L. Lakomkin, A.F. Vanin, A.A. Timoshin, V.I. Kapelko, and E.I. Chazov Long-lasting hypotensive action of stable preparations of dinitrosyl-iron complexes with thiol-containing ligands in conscious normotensive and hypertensive rats Nitric Oxide 16 2007 413 418
104. S. Abboud, and D.J. Haile A novel mammalian iron-regulated protein involved in intracellular iron metabolism J. Biol. Chem. 275 2000 19906 19912
105. A.B. Shekhter, T.G. Rudenko, V.A. Serezhenkov, and A.F. Vanin [Dinitrosyl-iron complexes with cysteine or glutathione accelerate skin wound healing in animals] Biofizika 52 2007 539 547
106. M.A. Arkhipova, V.D. Mikoian, and A.F. Vanin [Effect of exogenous donors of nitric oxide and inhibitors of its enzymatic synthesis on experimental ischemic thrombosis in conjunctive veins of rabbit eyes] Biofizika 53 2008 315 325
107. A.A. Andreyev-Andriyevsky, V.D. Mikoyan, V.A. Serezhenkov, and A.F. Vanin Penile erectile activity of dinitrosyl iron complexes with thiol-containing ligands Nitric Oxide 24 2011 217 223
108. E.I. Veliev, S.V. Kotov, V.K. Shishlo, V.A. Serezhenkov, V.I. Lozinskii, and A.F. Vanin [Effect of dinitrosyl iron complexes with thiol-containing ligands on the penile cavernosum bodies in rats] Biofizika 53 2008 326 335
109. M.I. Remizova, N.I. Kochetygov, K.A. Gerbout, V.L. Lakomkin, A.A. Timoshin, E.N. Burgova, and A.F. Vanin Effect of dinitrosyl iron complexes with glutathione on hemorrhagic shock followed by saline treatment Eur. J. Pharmacol. 662 2011 40 46
110. J.L. Alencar, K. Chalupsky, M. Sarr, V. Schini-Kerth, A.F. Vanin, J.C. Stoclet, and B. Muller Inhibition of arterial contraction by dinitrosyl-iron complexes: critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation Biochem. Pharmacol. 66 2003 2365 2374
111. Y.J. Chen, W.C. Ku, L.T. Feng, M.L. Tsai, C.H. Hsieh, W.H. Hsu, W.F. Liaw, and C.H. Hung Nitric oxide physiological responses and delivery mechanisms probed by water-soluble Roussin's red ester and {Fe(NO)2}10 DNIC J. Am. Chem. Soc. 130 2008 10929 10938
112. I.S. Severina, O.G. Bussygina, N.V. Pyatakova, I.V. Malenkova, and A.F. Vanin Activation of soluble guanylate cyclase by NO donors - S-nitrosothiols, and dinitrosyl-iron complexes with thiol-containing ligands Nitric Oxide 8 2003 155 163
113. B. Muller, A.L. Kleschyov, and J.C. Stoclet Evidence for N-acetylcysteine-sensitive nitric oxide storage as dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta Br. J. Pharmacol. 119 1996 1281 1285
114. J.Z. Pedersen, F. De Maria, P. Turella, G. Federici, M. Mattei, R. Fabrini, K.F. Dawood, M. Massimi, A.M. Caccuri, and G. Ricci Glutathione transferases sequester toxic dinitrosyl-iron complexes in cells: a protection mechanism against excess nitric oxide J. Biol. Chem. 282 2007 6364 6371
115. R.N. Watts, and D.R. Richardson The mechanism of nitrogen monoxide (NO)-mediated iron mobilization from cells: NO intercepts iron before incorporation into ferritin and indirectly mobilizes iron from ferritin in a glutathione-dependent manner Eur. J. Biochem. 269 2002 3383 3392
116. C. Appenzeller-Herzog Glutathione- and non-glutathione-based oxidant control in the endoplasmic reticulum J. Cell Sci. 124 2011 847 855
117. A.P. Halestrap, and N.T. Price The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation Biochem. J. 343 Pt 2 1999 281 299
118. A.M. Pajor Sodium-coupled transporters for Krebs cycle intermediates Annu. Rev. Physiol. 61 1999 663 682
119. R.M. Graham, E.H. Morgan, and E. Baker Characterisation of citrate and iron citrate uptake by cultured rat hepatocytes J. Hepatol. 29 1998 603 613
120. R.M. Graham, E.H. Morgan, and E. Baker Ferric citrate uptake by cultured rat hepatocytes is inhibited in the presence of transferrin Eur. J. Biochem. 253 1998 139 145
121. R.Y. Lin, J.C. Vera, R.S. Chaganti, and D.W. Golde Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter J. Biol. Chem. 273 1998 28959 28965
122. R.M. Clancy, D. Levartovsky, J. Leszczynska-Piziak, J. Yegudin, and S.B. Abramson Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary Proc. Natl. Acad. Sci. USA 91 1994 3680 3684
123. O.W. Griffith, and A. Meister Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine) J. Biol. Chem. 254 1979 7558 7560
124. E.M. Leslie, A. Haimeur, and M.P. Waalkes Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required J. Biol. Chem. 279 2004 32700 32708
125. M.J. Flens, G.J. Zaman, P. van der Valk, M.A. Izquierdo, A.B. Schroeijers, G.L. Scheffer, P. van der Groep, M. de Haas, C.J. Meijer, and R.J. Scheper Tissue distribution of the multidrug resistance protein Am. J. Pathol. 148 1996 1237 1247
126. Y.X. Hou, L. Cui, J.R. Riordan, and X.B. Chang ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain J. Biol. Chem. 277 2002 5110 5119
127. S.P. Cole, G. Bhardwaj, J.H. Gerlach, J.E. Mackie, C.E. Grant, K.C. Almquist, A.J. Stewart, E.U. Kurz, A.M. Duncan, and R.G. Deeley Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 1992 1650 1654
128. S.E. Mirski, J.H. Gerlach, and S.P. Cole Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin Cancer Res. 47 1987 2594 2598
129. X.B. Chang Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1 Methods Mol. Biol. 596 2010 223 249
130. D.R. Richardson DNIC and intracellular iron E. Van Faassen, A.F. Vanin, Radicals for Life: the Various Forms of Nitric Oxide 2007 Elsevier San Diego
131. Y.Y. He, J.L. Huang, D.C. Ramirez, and C.F. Chignell Role of reduced glutathione efflux in apoptosis of immortalized human keratinocytes induced by UVA J. Biol. Chem. 278 2003 8058 8064
132. R. Franco, M.I. Panayiotidis, and J.A. Cidlowski Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive oxygen species formation J. Biol. Chem. 282 2007 30452 30465
133. D.R. Richardson, and K. Milnes The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. II. The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone Blood 89 1997 3025 3038
134. P. Ponka, D. Richardson, E. Baker, H.M. Schulman, and J.T. Edward Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes Biochim. Biophys. Acta 967 1988 122 129
135. D.R. Richardson, and E. Baker The release of iron and transferrin from the human melanoma cell Biochim. Biophys. Acta 1091 1991 294 302
136. A. Donovan, A. Brownlie, Y. Zhou, J. Shepard, S.J. Pratt, J. Moynihan, B.H. Paw, A. Drejer, B. Barut, A. Zapata, T.C. Law, C. Brugnara, S.E. Lux, G.S. Pinkus, J.L. Pinkus, P.D. Kingsley, J. Palis, M.D. Fleming, N.C. Andrews, and L.I. Zon Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter Nature 403 2000 776 781
137. A.T. McKie, P. Marciani, A. Rolfs, K. Brennan, K. Wehr, D. Barrow, S. Miret, A. Bomford, T.J. Peters, F. Farzaneh, M.A. Hediger, M.W. Hentze, and R.J. Simpson A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation Mol. Cell 5 2000 299 309
138. E. Nemeth, M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, D.M. Ward, T. Ganz, and J. Kaplan Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 2004 2090 2093
139. L. Ghibelli, C. Fanelli, G. Rotilio, E. Lafavia, S. Coppola, C. Colussi, P. Civitareale, and M.R. Ciriolo Rescue of cells from apoptosis by inhibition of active GSH extrusion FASEB J. 12 1998 479 486
140. J.C. Drapier, and J.B. Hibbs Jr. Aconitases: a class of metalloproteins highly sensitive to nitric oxide synthesis Methods Enzymol. 269 1996 26 36
141. H. Ding, and B. Demple Glutathione-mediated destabilization in vitro of [2Fe-2S] centers in the SoxR regulatory protein Proc. Natl. Acad. Sci. USA 93 1996 9449 9453
142. P.A. Rogers, and H. Ding L-Cysteine-mediated destabilization of dinitrosyl iron complexes in proteins J. Biol. Chem. 276 2001 30980 30986
143. I. Leier, G. Jedlitschky, U. Buchholz, S.P. Cole, R.G. Deeley, and D. Keppler The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates J. Biol. Chem. 269 1994 27807 27810
144. K.V. Cullen, R.A. Davey, and M.W. Davey Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells Biochem. Pharmacol. 62 2001 417 424
145. D. Trompier, X.B. Chang, R. Barattin, A. du Moulinet D'Hardemare, A. Di Pietro, and H. Baubichon-Cortay Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1 Cancer Res. 64 2004 4950 4956
146. E. Bakos, and L. Homolya Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1) Pflugers Arch. 453 2007 621 641
147. G. Jedlitschky, I. Leier, U. Buchholz, K. Barnouin, G. Kurz, and D. Keppler Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump Cancer Res. 56 1996 988 994
148. J. Hirrlinger, J. Konig, D. Keppler, J. Lindenau, J.B. Schulz, and R. Dringen The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress J. Neurochem. 76 2001 627 636
149. C.F. Mueller, J.D. Widder, J.S. McNally, L. McCann, D.P. Jones, and D.G. Harrison The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress Circ. Res. 97 2005 637 644
150. S.P. Cole, K.E. Sparks, K. Fraser, D.W. Loe, C.E. Grant, G.M. Wilson, and R.G. Deeley Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells Cancer Res. 54 1994 5902 5910
151. C.E. Grant, G. Valdimarsson, D.R. Hipfner, K.C. Almquist, S.P. Cole, and R.G. Deeley Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs Cancer Res. 54 1994 357 361
152. D.W. Loe, R.G. Deeley, and S.P. Cole Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione Cancer Res. 58 1998 5130 5136
153. C. Calatozzolo, M. Gelati, E. Ciusani, F.L. Sciacca, B. Pollo, L. Cajola, C. Marras, A. Silvani, L. Vitellaro-Zuccarello, D. Croci, A. Boiardi, and A. Salmaggi Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma J. Neurooncol. 74 2005 113 121
154. C.S. Morrow, C. Peklak-Scott, B. Bishwokarma, T.E. Kute, P.K. Smitherman, and A.J. Townsend Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux Mol. Pharmacol. 69 2006 1499 1505
155. K. Swerts, B. De Moerloose, C. Dhooge, G. Laureys, Y. Benoit, and J. Philippe Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia Eur. J. Cancer 42 2006 295 309
156. M. Haber, J. Smith, S.B. Bordow, C. Flemming, S.L. Cohn, W.B. London, G.M. Marshall, and M.D. Norris Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma J. Clin. Oncol. 24 2006 1546 1553
157. J. Martin-Broto, A.M. Gutierrez, R.F. Ramos, J.A. Lopez-Guerrero, S. Ferrari, S. Stacchiotti, P. Picci, S. Calabuig, P. Collini, M. Gambarotti, S. Bague, A.P. Dei Tos, E. Palassini, P. Luna, J. Cruz, R. Cubedo, J. Martinez-Trufero, A. Poveda, P.G. Casali, A. Fernandez-Serra, A. Lopez-Pousa, and A. Gronchi MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study Mol. Cancer Ther. 13 2014 249 259
158. P. Depeille, P. Cuq, S. Mary, I. Passagne, A. Evrard, D. Cupissol, and L. Vian Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects Mol. Pharmacol. 65 2004 897 905
159. P. Depeille, P. Cuq, I. Passagne, A. Evrard, and L. Vian Combined effects of GSTP1 and MRP1 in melanoma drug resistance Br. J. Cancer 93 2005 216 223
160. C. Peklak-Scott, P.K. Smitherman, A.J. Townsend, and C.S. Morrow Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin Mol. Cancer Ther. 7 2008 3247 3255
161. M.B. Sibhatu, P.K. Smitherman, A.J. Townsend, and C.S. Morrow Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane Carcinogenesis 29 2008 807 815
162. C.S. Morrow, P.K. Smitherman, S.K. Diah, E. Schneider, and A.J. Townsend Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification: mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells J. Biol. Chem. 273 1998 20114 20120
163. C.M. Paumi, B.G. Ledford, P.K. Smitherman, A.J. Townsend, and C.S. Morrow Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance: kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity J. Biol. Chem. 276 2001 7952 7956
164. J.D. Hayes, J.U. Flanagan, and I.R. Jowsey Glutathione transferases Annu. Rev. Pharmacol. Toxicol. 45 2005 51 88
165. D. Sheehan, G. Meade, V.M. Foley, and C.A. Dowd Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily Biochem. J. 360 2001 1 16
166. B. Mannervik, P.G. Board, J.D. Hayes, I. Listowsky, and W.R. Pearson Nomenclature for mammalian soluble glutathione transferases Methods Enzymol. 401 2005 1 8
167. K. Sato, A. Kitahara, K. Satoh, T. Ishikawa, M. Tatematsu, and N. Ito The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis Gann 75 1984 199 202
168. 2 Proc. Natl. Acad. Sci. USA 98 2001 355 360
169. B. Xue, Y. Wu, Z. Yin, H. Zhang, S. Sun, T. Yi, and L. Luo Regulation of lipopolysaccharide-induced inflammatory response by glutathione S-transferase P1 in RAW264.7 cells FEBS Lett. 579 2005 4081 4087
170. P.S. Silverstein, K.L. Audus, N. Qureshi, and A. Kumar Lipopolysaccharide increases the expression of multidrug resistance-associated protein 1 (MRP1) in RAW 264.7 macrophages J. Neuroimmune Pharmacol. 5 2010 516 520
171. H. Ikeda, S. Nishi, and M. Sakai Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis Biochem. J. 380 2004 515 521
172. A. Hayashi, H. Suzuki, K. Itoh, M. Yamamoto, and Y. Sugiyama Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts Biochem. Biophys. Res. Commun. 310 2003 824 829
173. S. Dhakshinamoorthy, and A.G. Porter Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells J. Biol. Chem. 279 2004 20096 20107
174. J.D. Hayes, and D.J. Pulford The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance Crit. Rev. Biochem. Mol. Biol. 30 1995 445 600
175. G. Litwack, B. Ketterer, and I.M. Arias Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions Nature 234 1971 466 467
176. E. Tipping, B. Ketterer, and P. Koskelo The binding of porphyrins by ligandin Biochem. J. 169 1978 509 516
177. U.H. Danielson, and B. Mannervik Kinetic independence of the subunits of cytosolic glutathione transferase from the rat Biochem. J. 231 1985 263 267
178. D.M. Townsend, Y. Manevich, L. He, S. Hutchens, C.J. Pazoles, and K.D. Tew Novel role for glutathione S-transferase pi: regulator of protein S-glutathionylation following oxidative and nitrosative stress J. Biol. Chem. 284 2009 436 445
179. C.J. Henderson, and C.R. Wolf Knockout and transgenic mice in glutathione transferase research Drug Metab. Rev. 43 2011 152 164
180. D.M. Townsend, K.D. Tew, L. He, J.B. King, and M.H. Hanigan Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity Biomed. Pharmacother. 63 2009 79 85
181. C.J. Henderson, C.R. Wolf, N. Kitteringham, H. Powell, D. Otto, and B.K. Park Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi Proc. Natl. Acad. Sci. USA 97 2000 12741 12745
182. D.J. Conklin, P. Haberzettl, J.F. Lesgards, R.A. Prough, S. Srivastava, and A. Bhatnagar Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity J. Pharmacol. Exp. Ther. 331 2009 456 469
183. D.J. Conklin, P. Haberzettl, R.A. Prough, and A. Bhatnagar Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke Am. J. Physiol. Heart Circ. Physiol. 296 2009 H1586 H1597
184. C.J. Henderson, A.G. Smith, J. Ure, K. Brown, E.J. Bacon, and C.R. Wolf Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases Proc. Natl. Acad. Sci. USA 95 1998 5275 5280
185. K.J. Ritchie, S. Walsh, O.J. Sansom, C.J. Henderson, and C.R. Wolf Markedly enhanced colon tumorigenesis in Apc(Min) mice lacking glutathione S-transferase Pi Proc. Natl. Acad. Sci. USA 106 2009 20859 20864
186. K.J. Ritchie, C.J. Henderson, X.J. Wang, O. Vassieva, D. Carrie, P.B. Farmer, M. Gaskell, K. Park, and C.R. Wolf Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane Cancer Res. 67 2007 9248 9257
187. L. Gate, R.S. Majumdar, A. Lunk, and K.D. Tew Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice Int. J. Cancer 113 2005 29 35
188. A. Re, A. Aiello, S. Nanni, A. Grasselli, V. Benvenuti, V. Pantisano, L. Strigari, C. Colussi, S. Ciccone, A.P. Mazzetti, F. Pierconti, F. Pinto, P. Bassi, M. Gallucci, S. Sentinelli, F. Trimarchi, S. Bacchetti, A. Pontecorvi, M. Lo Bello, and A. Farsetti Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-beta and endothelial nitric oxide synthase complex Mol. Endocrinol. 25 2011 2003 2016
189. V. Hauptstock, S. Kuriakose, D. Schmidt, R. Duster, S.C. Muller, A. von Ruecker, and J. Ellinger Glutathione-S-transferase pi 1 (GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide Biochem. Biophys. Res. Commun. 412 2011 606 611
190. J.Z. Song, C. Stirzaker, J. Harrison, J.R. Melki, and S.J. Clark Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells Oncogene 21 2002 1048 1061
191. W.G. Nelson, A.M. De Marzo, T.L. Deweese, X. Lin, J.D. Brooks, M.J. Putzi, C.P. Nelson, J.D. Groopman, and T.W. Kensler Preneoplastic prostate lesions: an opportunity for prostate cancer prevention Ann. N. Y. Acad. Sci. 952 2001 135 144
192. R. Elsby, N.R. Kitteringham, C.E. Goldring, C.A. Lovatt, M. Chamberlain, C.J. Henderson, C.R. Wolf, and B.K. Park Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi J. Biol. Chem. 278 2003 22243 22249
193. V. Adler, Z. Yin, S.Y. Fuchs, M. Benezra, L. Rosario, K.D. Tew, M.R. Pincus, M. Sardana, C.J. Henderson, C.R. Wolf, R.J. Davis, and Z. Ronai Regulation of JNK signaling by GSTp EMBO J. 18 1999 1321 1334
194. 2-induced cell death via coordinated regulation of stress kinases Cancer Res. 60 2000 4053 4057
195. S.G. Cho, Y.H. Lee, H.S. Park, K. Ryoo, K.W. Kang, J. Park, S.J. Eom, M.J. Kim, T.S. Chang, S.Y. Choi, J. Shim, Y. Kim, M.S. Dong, M.J. Lee, S.G. Kim, H. Ichijo, and E.J. Choi Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1 J. Biol. Chem. 276 2001 12749 12755
196. H. Ichijo, E. Nishida, K. Irie, P. ten Dijke, M. Saitoh, T. Moriguchi, M. Takagi, K. Matsumoto, K. Miyazono, and Y. Gotoh Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways Science 275 1997 90 94
197. R. Kodym, P. Calkins, and M. Story The cloning and characterization of a new stress response protein: a mammalian member of a family of theta class glutathione S-transferase-like proteins J. Biol. Chem. 274 1999 5131 5137
198. D.W. Voehringer, D.L. Hirschberg, J. Xiao, Q. Lu, M. Roederer, C.B. Lock, L.A. Herzenberg, and L. Steinman Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis Proc. Natl. Acad. Sci. USA 97 2000 2680 2685
199. R.C. Cumming, J. Lightfoot, K. Beard, H. Youssoufian, P.J. O'Brien, and M. Buchwald Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1 Nat. Med. 7 2001 814 820
200. K.D. Tew Glutathione-associated enzymes in anticancer drug resistance Cancer Res. 54 1994 4313 4320
201. D.M. Townsend, and K.D. Tew The role of glutathione-S-transferase in anti-cancer drug resistance Oncogene 22 2003 7369 7375
202. R.R. Starzynski, A.S. Goncalves, F. Muzeau, Z. Tyrolczyk, E. Smuda, J.C. Drapier, C. Beaumont, and P. Lipinski STAT5 proteins are involved in down-regulation of iron regulatory protein 1 gene expression by nitric oxide Biochem. J. 400 2006 367 375
203. M.A. Keese, M. Bose, A. Mulsch, R.H. Schirmer, and K. Becker Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase Biochem. Pharmacol. 54 1997 1307 1313
204. M. Lo Bello, M. Nuccetelli, A.M. Caccuri, L. Stella, M.W. Parker, J. Rossjohn, W.J. McKinstry, A.F. Mozzi, G. Federici, F. Polizio, J.Z. Pedersen, and G. Ricci Human glutathione transferase P1-1 and nitric oxide carriers; a new role for an old enzyme J. Biol. Chem. 276 2001 42138 42145
205. E. Cesareo, L.J. Parker, J.Z. Pedersen, M. Nuccetelli, A.P. Mazzetti, A. Pastore, G. Federici, A.M. Caccuri, G. Ricci, J.J. Adams, M.W. Parker, and M. Lo Bello Nitrosylation of human glutathione transferase P1-1 with dinitrosyl diglutathionyl iron complex in vitro and in vivo J. Biol. Chem. 280 2005 42172 42180
206. C.S. Morrow, S. Diah, P.K. Smitherman, E. Schneider, and A.J. Townsend Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity Carcinogenesis 19 1998 109 115
207. C.S. Morrow, P.K. Smitherman, and A.J. Townsend Combined expression of multidrug resistance protein (MRP) and glutathione S-transferase P1-1 (GSTP1-1) in MCF7 cells and high level resistance to the cytotoxicities of ethacrynic acid but not oxazaphosphorines or cisplatin Biochem. Pharmacol. 56 1998 1013 1021
208. L. Stella, V. Pallottini, S. Moreno, S. Leoni, F. De Maria, P. Turella, G. Federici, R. Fabrini, K.F. Dawood, M.L. Bello, J.Z. Pedersen, and G. Ricci Electrostatic association of glutathione transferase to the nuclear membrane: evidence of an enzyme defense barrier at the nuclear envelope J. Biol. Chem. 282 2007 6372 6379
209. S. Kim, and P. Ponka Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2 J. Biol. Chem. 275 2000 6220 6226
210. T. Asano, M. Komatsu, Y. Yamaguchi-Iwai, F. Ishikawa, N. Mizushima, and K. Iwai Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells Mol. Cell. Biol. 31 2011 2040 2052
211. H. Lewandowska, S. Meczynska, B. Sochanowicz, J. Sadlo, and M. Kruszewski Crucial role of lysosomal iron in the formation of dinitrosyl iron complexes in vivo J. Biol. Inorg. Chem. 12 2007 345 352
212. A. de Luca, N. Moroni, A. Serafino, A. Primavera, A. Pastore, J.Z. Pedersen, R. Petruzzelli, M.G. Farrace, P. Pierimarchi, G. Moroni, G. Federici, P. Sinibaldi Vallebona, and M. Lo Bello Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance Biochem. J. 440 2011 175 183
213. M. Kawakatsu, S. Goto, T. Yoshida, Y. Urata, and T.S. Li Nuclear translocation of glutathione S-transferase Pi is mediated by a nonclassical localization signal Biochem. Biophys. Res. Commun. 411 2011 745 750
214. S.S. Qazi, A. Osoria Perez, M. Sam, and E.M. Leslie Glutathione transferase P1 interacts strongly with the inner leaflet of the plasma membrane Drug Metab. Dispos. 39 2011 1122 1126
215. P. Canto, T. Canto-Cetina, R. Juarez-Velazquez, H. Rosas-Vargas, H. Rangel-Villalobos, S. Canizales-Quinteros, A.C. Velazquez-Wong, M.T. Villarreal-Molina, G. Fernandez, and R. Coral-Vazquez Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women Hypertens. Res. 31 2008 1015 1019
216. P.L. Zusterzeel, W. Visser, W.H. Peters, H.W. Merkus, W.L. Nelen, and E.A. Steegers Polymorphism in the glutathione S-transferase P1 gene and risk for preeclampsia Obstet. Gynecol. 96 2000 50 54
217. E. Capoluongo, G. Onder, P. Concolino, A. Russo, C. Santonocito, R. Bernabei, C. Zuppi, F. Ameglio, and F. Landi GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente Geographic Area (ilSIRENTE study) Clin. Chim. Acta 399 2009 92 96
218. M.W. McBride, M.J. Brosnan, J. Mathers, L.I. McLellan, W.H. Miller, D. Graham, N. Hanlon, C.A. Hamilton, J.M. Polke, W.K. Lee, and A.F. Dominiczak Reduction of Gstm1 expression in the stroke-prone spontaneously hypertensive rat contributes to increased oxidative stress Hypertension 45 2005 786 792
219. M. Boese, P.I. Mordvintcev, A.F. Vanin, R. Busse, and A. Mulsch S-nitrosation of serum albumin by dinitrosyl-iron complex J. Biol. Chem. 270 1995 29244 29249
220. A.F. Vanin, I.V. Malenkova, and V.A. Serezhenkov Iron catalyzes both decomposition and synthesis of S-nitrosothiols: optical and electron paramagnetic resonance studies Nitric Oxide 1 1997 191 203
221. N. Maio, A. Singh, H. Uhrigshardt, N. Saxena, W.H. Tong, and T.A. Rouault Cochaperone binding to LYR motifs confers specificity of iron sulfur cluster delivery Cell Metab. 19 2014 445 457
222. D.J. Lane, A.M. Merlot, and D.R. Richardson The lure of a LYR: the logistics of iron sulfur cluster delivery Cell Metab. 19 2014 348 350
223. S. Mocellin, V. Bronte, and D. Nitti Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities Med. Res. Rev. 27 2007 317 352
224. A. Zai, M.A. Rudd, A.W. Scribner, and J. Loscalzo Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide J. Clin. Invest. 103 1999 393 399